Interference of Bifidobacterium choerinum or Escherichia coli Nissle 1917 with Salmonella Typhimurium in gnotobiotic piglets correlates with cytokine patterns in blood and intestine

Clinical and Experimental Immunology

Volumn 163, Issue 2, 2011, Pages 242-249

  Splichalova, A ^a   Trebichavsky, I ^a   Rada, V ^b   Vlkova, E ^b   Sonnenborn, U ^c   Splichal, I ^a  

^a INSTITUTE OF MICROBIOLOGY   (Czech Republic)

^b CZECH UNIVERSITY OF LIFE SCIENCES PRAGUE   (Czech Republic)

^c Ardeypharm GmbH   (Germany)

Author keywords

Bifidobacterium; Cytokine; Gnotobiotic pig; Nissle 1917; Salmonella

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 8; PROBIOTIC AGENT; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBIOSIS; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL TRANSLOCATION; BIFIDOBACTERIUM; BIFIDOBACTERIUM CHOERINUM; CONTROLLED STUDY; CYTOKINE RESPONSE; ESCHERICHIA COLI; GNOTOBIOTICS; ILEUM; INTESTINE LAVAGE; MESENTERY LYMPH NODE; NONHUMAN; PIGLET; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SALMONELLA TYPHIMURIUM; SALMONELLOSIS; SEPTICEMIA; SYSTEMIC CIRCULATION;

ANIMALS; ANTIBIOSIS; BIFIDOBACTERIUM; COLON; CYTOKINES; ESCHERICHIA COLI; GERM-FREE LIFE; ILEUM; INTESTINES; PROBIOTICS; SALMONELLA INFECTIONS, ANIMAL; SALMONELLA TYPHIMURIUM; SWINE;

EID: 78650823747     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2010.04283.x     Document Type: Article

References (56)

1. Dethlefsen L, McFall-Ngai M, Relman DA. An ecological and evolutionary perspective on human-microbe mutualism and disease. Nature 2007; 449:811-18.
2. Eckburg PB, Bik EM, Bernstein CN et al. Diversity of the human intestinal microbial flora. Science 2005; 308:1635-8.
3. van der Waaij D. Colonization resistance of the digestive tract: clinical consequences and implications. J Antimicrob Chemother 1982; 10:263-70.
4. Senok AC, Ismaeel AY, Botta GA. Probiotics: facts and myths. Clin Microbiol Infect 2005; 11:958-66.
5. Guarner F. Enteric flora in health and disease. Digestion 2006; 73 (Suppl. 1):5-12.
6. Biasucci G, Rubini M, Riboni S, Morelli L, Bessi E, Retetangos C. Mode of delivery affects the bacterial community in the newborn gut. Early Hum Dev 2010; 86 (Suppl. 1):13-15.
7. Mikkelsen LL, Jensen BB. Effect of fructo-oligosaccharides and transgalacto-oligosaccharides on microbial populations and microbial activity in the gastrointestinal tract of piglets post-weaning. Anim Feed Sci Technol 2004; 117:107-19.
8. Reuter G. The Lactobacillus and Bifidobacterium microflora of the human intestine: composition and succession. Curr Issues Intest Microbiol 2001; 2:43-53.
9. Vlkova E, Trojanova I, Rada V. Distribution of bifidobacteria in the gastrointestinal tract of calves. Folia Microbiol (Praha) 2006; 51:325-8.
10. Huurre A, Kalliomaki M, Rautava S, Rinne M, Salminen S, Isolauri E. Mode of delivery - effects on gut microbiota and humoral immunity. Neonatology 2008; 93:236-40.
11. Shim SB, Verstegen MW, Kim IH, Kwon OS, Verdonk JM. Effects of feeding antibiotic-free creep feed supplemented with oligofructose, probiotics or synbiotics to suckling piglets increases the preweaning weight gain and composition of intestinal microbiota. Arch Anim Nutr 2005; 59:419-27.
12. Fava F, Makivuokko H, Siljander-Rasi H et al. Effect of polydextrose on intestinal microbes and immune functions in pigs. Br J Nutr 2007; 98:123-33.
13. Franklin MA, Mathew AG, Vickers JR, Clift RA. Characterization of microbial populations and volatile fatty acid concentrations in the jejunum, ileum, and cecum of pigs weaned at 17 vs 24 days of age. J Anim Sci 2002; 80:2904-10.
14. Letellier A, Messier S, Lessard L, Quessy S. Assessment of various treatments to reduce carriage of Salmonella in swine. Can J Vet Res 2000; 6:27-31.
15. Maxwell FJ, Duncan SH, Hold G, Stewart CS. Isolation, growth on prebiotics and probiotic potential of novel bifidobacteria from pigs. Anaerobe 2004; 10:33-9.
16. Schultz M. Escherichia coli. In: Versalovic J, Wilson M, eds. Therapeutic microbiology: probiotics and related strategies. Washington, DC: ASM Press, 2008:83-96.
17. Nissle A. Antagonistic treatment of chronic intestinal diseases with colibacteria. Med Klinik 1918; 2:29-30.
18. Henker J, Laass M, Blokhin BM et al. The probiotic Escherichia coli strain Nissle 1917 (EcN) stops acute diarrhoea in infants and toddlers. Eur J Pediatr 2007; 166:311-18.
19. von Buenau R, Jaekel L, Schubotz E, Schwarz S, Stroff T, Krueger M. Escherichia coli strain Nissle 1917: significant reduction of neonatal calf diarrhea. J Dairy Sci 2005; 88:317-23.
20. Barth S, Duncker S, Hempe J, Breves G, Baljer G, Bauerfeind R. Escherichia coli Nissle 1917 for probiotic use in piglets: evidence for intestinal colonization. J Appl Microbiol 2009; 107:1697-710.
21. Schroeder B, Duncker S, Barth S et al. Preventive effects of the probiotic Escherichia coli strain Nissle 1917 on acute secretory diarrhea in a pig model of intestinal infection. Dig Dis Sci 2006; 51:724-31.
22. Vassiliadis G, Destoumieux-Garzon D, Lombard C, Rebuffat S, Peduzzi J. Isolation and characterization of two members of the siderophore-microcin family, microcins M and H47. Antimicrob Agents Chemother 2010; 54:288-97.
23. Altenhoefer A, Oswald S, Sonnenborn U et al. The probiotic Escherichia coli strain Nissle 1917 interferes with invasion of human intestinal epithelial cells by different enteroinvasive bacterial pathogens. FEMS Immunol Med Microbiol 2004; 40:223-9.
24. Menard O, Butel MJ, Gaboriau-Routhiau V, Waligora-Dupriet AJ. Gnotobiotic mouse immune response induced by Bifidobacterium sp. strains isolated from infants. Appl Environ Microbiol 2008; 74:660-6.
25. Foster N, Lovell MA, Marston KL et al. Rapid protection of gnotobiotic pigs against experimental salmonellosis following induction of polymorphonuclear leukocytes by avirulent Salmonella enterica. Infect Immun 2003; 71:2182-91.
26. Trebichavsky I, Schulze J, Dlabac V, Cukrowska B, Tlaskalova-Hogenova H, Rehakova Z. Salmonellosis: lessons drawn from a germ-free pig model. Folia Microbiol (Praha) 1998; 43:697-701.
27. Inman CF, Haverson K, Konstantinov SR et al. Rearing environment affects development of the immune system in neonates. Clin Exp Immunol 2010; 160:431-9.
28. Mandel L, Travnicek J. The minipig as a model in gnotobiology. Nahrung 1987; 31:613-18.
29. Dlabac V. Report from a meeting of the committee for standardization of control of germfree state. Folia Microbiol (Praha) 1980; 25:354-8.
30. Rada V, Petr J. A new selective medium for the isolation of glucose non-fermenting bifidobacteria from hen caeca. J Microbiol Methods 2000; 43:127-32.
31. Sakata S, Kitahara M, Sakamoto M, Hayashi H, Fukuyama M, Benno Y. Unification of Bifidobacterium infantis and Bifidobacterium suis as Bifidobacterium longum. Int J Syst Evol Microbiol 2002; 52:1945-51.
32. Splichal I, Muneta Y, Mori Y, Takahashi E. Development and application of a pig IL-8 ELISA detection system. J Immunoassay Immunochem 2003; 24:219-32.
33. Kankwatira AM, Mwafulirwa GA, Gordon MA. Non-typhoidal salmonella bacteraemia - an under-recognized feature of AIDS in African adults. Trop Doct 2004; 34:198-200.
34. Nyachuba DG. Foodborne illness: is it on the rise? Nutr Rev 2010; 68:257-69.
35. Hapfelmeier S, Hardt WD. A mouse model for S. typhimurium-induced enterocolitis. Trends Microbiol 2005; 13:497-503.
36. Mastroeni P, Sheppard M. Salmonella infections in the mouse model: host resistance factors and in vivo dynamics of bacterial spread and distribution in the tissues. Microbes Infect 2004; 6:398-405.
37. Silva AM, Barbosa FH, Duarte R, Vieira LQ, Arantes RM, Nicoli JR. Effect of Bifidobacterium longum ingestion on experimental salmonellosis in mice. J Appl Microbiol 2004; 97:29-37.
38. Kleta S, Steinruck H, Breves G et al. Detection and distribution of probiotic Escherichia coli Nissle 1917 clones in swine herds in Germany. J Appl Microbiol 2006; 101:1357-66.
39. Splichal I, Fagerhol MK, Trebichavsky I, Splichalova A, Schulze J. The effect of intestinal colonization of germ-free pigs with Escherichia coli on calprotectin levels in plasma, intestinal and bronchoalveolar lavages. Immunobiology 2005; 209:681-7.
40. Hancock V, Dahl M, Klemm P. Probiotic Escherichia coli strain Nissle 1917 outcompetes intestinal pathogens during biofilm formation. J Med Microbiol 2010; 59:392-9.
41. Hudcovic T, Stepankova R, Kozakova H, Hrncir T, Tlaskalova-Hogenova H. Effects of monocolonization with Escherichia coli strains O6K13 and Nissle 1917 on the development of experimentally induced acute and chronic intestinal inflammation in germ-free immunocompetent and immunodeficient mice. Folia Microbiol (Praha) 2007; 52:618-26.
42. Mandel L, Trebichavsky I, Splichal I, Schulze J. Stimulation of intestinal immune cells by E. coli in gnotobiotic piglets. In: Mestecky J, ed. Advances in mucosal immunology. New York: Plenum Press, 1995:463-4.
43. Splichal I, Trebichavsky I, Splichalova A, Barrow PA. Protection of gnotobiotic pigs against Salmonella enterica serotype Typhimurium by rough mutant of the same serotype is accompanied by the change of local and systemic cytokine response. Vet Immunol Immunopathol 2005; 103:155-61.
44. Zeng H, Carlson AQ, Guo Y et al. Flagellin is the major proinflammatory determinant of enteropathogenic Salmonella. J Immunol 2003; 171:3668-74.
45. Hafez M, Hayes K, Goldrick M, Warhurst G, Grencis R, Roberts IS. The K5 capsule of Escherichia coli strain Nissle 1917 is important in mediating interactions with intestinal epithelial cells and chemokine induction. Infect Immun 2009; 77:2995-3003.
46. Schlee M, Wehkamp J, Altenhoefer A, Oelschlaeger TA, Stange EF, Fellermann K. Induction of human beta-defensin 2 by the probiotic Escherichia coli Nissle 1917 is mediated through flagellin. Infect Immun 2007; 75:2399-407.
47. Thorgersen EB, Hellerud BC, Nielsen EW et al. CD14 inhibition efficiently attenuates early inflammatory and hemostatic responses in Escherichia coli sepsis in pigs. FASEB J 2010; 24:712-22.
48. Nielsen EW, Hellerud BC, Thorgersen EB et al. A new dynamic porcine model of meningococcal shock. Shock 2009; 32:302-9.
49. Pie S, Matsiota-Bernard P, Truffa-Bachi P, Nauciel C. Gamma interferon and interleukin-10 gene expression in innately susceptible and resistant mice during the early phase of Salmonella typhimurium infection. Infect Immun 1996; 64:849-54.
50. Kruse R, Essen-Gustavsson B, Fossum C, Jensen-Waern M. Blood concentrations of the cytokines IL-1beta, IL-6, IL-10, TNF-alpha and IFN-gamma during experimentally induced swine dysentery. Acta Vet Scand 2008; 50:32.
51. Jesmok G, Lindsey C, Duerr M, Fournel M, Emerson T Jr. Efficacy of monoclonal antibody against human recombinant tumor necrosis factor in E. coli-challenged swine. Am J Pathol 1992; 141:1197-207.
52. Searle LE, Best A, Nunez A et al. A mixture containing galactooligosaccharide, produced by the enzymic activity of Bifidobacterium bifidum, reduces Salmonella enterica serovar Typhimurium infection in mice. J Med Microbiol 2009; 58:37-48.
53. Bayoumi MA, Griffiths MW. Probiotics down-regulate genes in Salmonella enterica serovar typhimurium pathogenicity islands 1 and 2. J Food Prot 2010; 73:452-60.
54. O'Mahony C, Scully P, O'Mahony D et al. Commensal-induced regulatory T cells mediate protection against pathogen-stimulated NF-kappaB activation. PLoS Pathog 2008; 4:e1000112.
55. Kleessen B, Blaut M. Modulation of gut mucosal biofilms. Br J Nutr 2005; 93 (Suppl. 1):S35-40.
56. Trebichavsky I, Rada V, Splichalova A, Splichal I. Cross-talk of human gut with bifidobacteria. Nutr Rev 2009; 67:77-82.